An aspirin a day really does keep heart attack and stroke away for women, yet fewer than half of American women who could benefit from the simple measure do not take a daily pill, according to recent research.

San Francisco-based McKesson announced it has agreed to purchase Per-Se Technologies, Alpharetta, Ga., in a deal worth $1.8 billion. The purchase is expected to close in the first quarter of 2007 if it meets regulatory approval.

Washington University surgeons at Barnes-Jewish Hospital, St. Louis, began training at UMC in Tucson on Nov. 2 to become ...

A new study published in the Oct. 30 edition of “Circulation” calls the onset of peripheral arterial disease (PAD) among ...

A dedicated interventional cardiology track is slated during the 2006 Scientific Sessions of the AHA in Chicago that ...

A new cooling pad enters the healthcare market, joining a growing number of cooling systems used to induce hypothermia ...

November 2006 - Physicians at UT Southwestern Medical Center are part of a multinational clinical trial evaluating the Optimizer System, a unique implantable device designed to treat a larger number of patients with heart failure. UT Southwestern is one of the top enrolling centers of the 50 sites in the U.S.

Boston Scientific has launched new software enabling its Left Ventricular (LV) Offset feature in the CONTAK RENEWAL ...